Single IV Dose of GLYX-13 in Patients With Treatment-Resistant Depression

Clinical trial NCT01234558 · COMPLETED

Trial details

NCT number: NCT01234558
Sponsor: Naurex, Inc, an affiliate of Allergan plc
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Major Depressive Disorder

Start date: 2011-05-01
Primary completion: 2012-06-01
Enrollment: 115

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.